MedTrace Logo

Maternal Adversity, Vulnerability and Neurodevelopment

NCT03434457 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 630

Last updated 2020-05-27

Study results available
· View outcomes & findings →

Summary

Maternal Adversity Vulnerability and Neurodevelopment (MAVAN) project is a prospective community-based, pregnancy and birth cohort of Canadian mother-child dyads. The main objective of MAVAN project is to examine the pre- and postnatal influences, and their interaction, in determining individual differences in children development. The MAVAN project is designed to examine the consequences of fetal adversity as a function of the quality of the postnatal environment, focusing on mother-infant interactions.

Conditions

  • Mental Health Issue (E.G., Depression, Psychosis, Personality Disorder, Substance Abuse)
  • Infant Development
  • Infant Behavior

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • The JPB Foundation

    collaborator UNKNOWN

  • Ludmer Family Foundation

    collaborator UNKNOWN

  • Norlien Foundation

    collaborator OTHER

  • WOCO Foundation

    collaborator UNKNOWN

  • Blema & Arnold Steinberg Family Foundation

    collaborator UNKNOWN

  • McGill University

    collaborator OTHER

  • Jacobs Foundation

    collaborator UNKNOWN

  • Douglas Mental Health University Institute

    lead OTHER

Principal Investigators

  • Michael J Meaney, PhD · James McGill Professor

Eligibility

Min Age
3 Months
Max Age
6 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-10-01
Primary Completion
2017-12-01
Completion
2017-12-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03434457 on ClinicalTrials.gov